Tag: TIGIT

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to TIGIT

New I-O Targets Herald a Decade of Drugging the Undruggable | BioSpace

Added to Collection on: 2023-01-13 17:23:01

Tags for this article:

Medicine
Medical specialties
Immune system
Clinical medicine
TIGIT
Compugen
Programmed cell death protein 1
Cancer immunotherapy
PD-1 and PD-L1 inhibitors
PD-L1
Checkpoint inhibitor
Immune checkpoint
Anat Cohen-Dayag
PD

Click the tags to see associated articles and topics

View Article Details
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi ...

Added to Collection on: 2023-10-28 16:14:08

Tags for this article:

Antineoplastic drugs
Orphan drugs
Breakthrough therapy
Cancer treatments
Cancer immunotherapy
TIGIT
Checkpoint inhibitor
Chemotherapy
Enteropathy-associated T-cell lymphoma
Treatment of lung cancer
Durvalumab
Shanghai
Gemcitabine
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
United States
China
Cisplatin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi Phase III trial raises trial design questions - Clinical Trials Arena

Added to Collection on: 2023-11-21 16:30:12

Tags for this article:

Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Immune system
Durvalumab
Checkpoint inhibitor
Pembrolizumab
Nivolumab
TIGIT
Non-small-cell lung cancer
PD-L1
Imfinzi

Click the tags to see associated articles and topics

View Article Details
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical Cancer

Added to Collection on: 2024-01-06 04:39:44

Tags for this article:

Orphan drugs
Atezolizumab
Bevacizumab
Survival rate
TIGIT
Durvalumab

Click the tags to see associated articles and topics

View Article Details
UCF “Beefing Up” Natural Killer Cells to Stop Cancer | University of Central Florida News

Added to Collection on: 2024-01-29 18:51:37

Tags for this article:

Immune system
Immunology
Lymphocytes
TIGIT
T cells
Cancer immunotherapy
Natural killer cell
Immunotherapy
Immunologic Constant of Rejection
Jane Grogan
NK cells
Alicja Copik

Click the tags to see associated articles and topics

View Article Details
Phanes Therapeutics, Inc. Announces Clinical Supply Agreement with Roche to ... - Morningstar

Added to Collection on: 2024-05-08 22:08:55

Tags for this article:

Lung cancer
Infectious causes of cancer
Orphan drugs
Cancer immunotherapy
Atezolizumab
Small-cell carcinoma
Checkpoint inhibitor
Bispecific monoclonal antibody
Roche
Neuroendocrine tumor
Treatment of lung cancer
TIGIT
Phanes Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
AstraZeneca sets lofty target of $80bn in revenues by 2030 - Pharmaphorum

Added to Collection on: 2024-05-21 16:57:26

Tags for this article:

Immunology
AstraZeneca
Medical research
Södertälje Municipality
Pascal Soriot
Bispecific monoclonal antibody
Antibody-drug conjugate
Deruxtecan
TIGIT
Greenhouse gas emissions
Antibody
Pfizer
Soriot

Click the tags to see associated articles and topics

View Article Details
CDSCO Panel Rejects Roche Products India local Phase III CT waiver proposal for ...

Added to Collection on: 2024-06-18 15:59:33

Tags for this article:

Orphan drugs
Atezolizumab
Injection
Subcutaneous administration
Cancer immunotherapy
TIGIT
Roche Products
India

Click the tags to see associated articles and topics

View Article Details
Merck stops testing combo drug for lung cancer | The Mighty 790 KFGO

Added to Collection on: 2024-08-08 17:04:40

Tags for this article:

Cancer immunotherapy
Virotherapy
Antineoplastic drugs
Orphan drugs
TIGIT
Lung cancer
Immunotherapy
Pembrolizumab
Small-cell carcinoma
Checkpoint inhibitor
Merck

Click the tags to see associated articles and topics

View Article Details
Long-Term KEYNOTE-006 Data Support Pembrolizumab as SOC in Advanced Melanoma

Added to Collection on: 2024-09-15 17:12:08

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Ipilimumab
Melanoma
Merck & Co.
Progression-free survival
Uveal melanoma
MRNA-4157/V940
TIGIT
Caroline Robert

Click the tags to see associated articles and topics

View Article Details